Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
about
Repurposing metformin: an old drug with new tricks in its binding pocketsUnexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerOvarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reductionOld drug, new trick: repurposing metformin for gynecologic cancers?Update on immune checkpoint inhibitors in gynecological cancersReversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy.Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers.Intact LKB1 activity is required for survival of dormant ovarian cancer spheroidsHyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancerThe Impact of Diabetes on Gynecologic Cancer: Current Status and Future Directions.Measuring the biological effect of presurgical metformin treatment in endometrial cancer.Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.Metformin targets multiple signaling pathways in cancer.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Combinational strategies of metformin and chemotherapy in cancers.Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancerMetformin may protect nondiabetic breast cancer women from metastasis.Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer.Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms.Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice.Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention.Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt.Metformin inhibits ovarian cancer growth and migration in vitro and in vivo by enhancing cisplatin cytotoxicity
P2860
Q22250976-22883CC1-8540-4602-A305-CA4624552725Q26750845-34645956-9DDC-4DC2-A9C5-85A644AC6309Q26780387-37D0A461-3DA6-4966-8C77-729029CB8BA1Q26786610-4759C796-F30A-47B2-939B-EF2A6B79FEF2Q27010558-87204685-7016-418B-806C-2A8B93937C99Q28076497-E81EEC8C-69CC-4CC0-98D8-66E593C95072Q36088140-3A36D14B-A650-4FCD-B161-F873F7505811Q36109555-BB437209-4EC3-4470-9AA3-A0099C0A8BA4Q36180542-13002FB3-1221-41B9-BD11-9BD6A36446B9Q36355979-15805488-D2C9-4984-9EC4-C6750CA6CE9BQ36414231-D1A692A9-F13F-42E0-83EB-394BE54EF9EEQ36494695-14A9C316-C0C0-4E40-B155-4AE484F81924Q36547907-72544E5B-7423-498C-B2BA-2718E410B29CQ37353982-14DB4062-2CCA-43F7-9C1D-E0B7FF15C4E9Q37609790-8C0B9A0A-8781-4999-A35A-C1BA95F50DF9Q38728567-5A58D425-FA19-412E-8CC9-5B181309B3D7Q38818730-711BD124-92E5-40CA-9EA7-09296FFD7C17Q42339119-54E4D83D-1927-46F7-9A93-77C26F6E04F5Q46244897-42CB3927-8C1A-40E3-97EA-EAF73CDB28C4Q47098834-68CA73FA-268A-4256-9EA5-44047FC734F7Q47777378-3D34B567-839D-44CE-BD5B-4B4453FFEF78Q47850215-A1126E2B-A640-4EA1-A780-900CDCA03DDBQ49194546-B8D69F2B-9531-4FC9-AAE6-69B7EEBD09DFQ50199885-8E825507-3811-4591-B30F-A8D95E297350Q51109209-92A552AA-2F58-48C0-8191-74DB45BFEDF1Q54221394-D56DEE79-3618-4079-A248-4ADECFAA569EQ58733981-32ADE619-A0AD-466E-8756-A7BA6BF738B6
P2860
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Metformin inhibits ovarian can ...... to paclitaxel in mouse models.
@ast
Metformin inhibits ovarian can ...... to paclitaxel in mouse models.
@en
type
label
Metformin inhibits ovarian can ...... to paclitaxel in mouse models.
@ast
Metformin inhibits ovarian can ...... to paclitaxel in mouse models.
@en
prefLabel
Metformin inhibits ovarian can ...... to paclitaxel in mouse models.
@ast
Metformin inhibits ovarian can ...... to paclitaxel in mouse models.
@en
P2093
P2860
P50
P1476
Metformin inhibits ovarian can ...... to paclitaxel in mouse models
@en
P2093
Abir Mukherjee
Alyssa Johnson
Anirban K Mitra
Kristin M Nieman
Lacey M Litchfield
WooSeok Lee
Yilin Zhang
P2860
P304
479.e1-479.e10
P356
10.1016/J.AJOG.2014.10.026
P407
P577
2014-10-19T00:00:00Z